Janssen's Best Practices For Patient Diversity Success
Janssen's Best Practices For Patient Diversity Success By Ed Miseta, Chief Editor, Clinical Leader Follow Me On Twitter @EdClinical As devastating as the COVID pandemic has been, one positive result is the increased attention it has shed on the pharmaceutical industry. Because of the quest to stop the spread of COVID and save lives, the public is now more aware of the difficulty of finding cures and vaccines, and the need for clinical trials. One report has even showed an improvement in the reputation of pharma. “With COVID there's a greater understanding about clinical research,” said Ca...
Source: clinicalleader.com